Counsyl provides actionable information that guides critical and timely health decisions.
Whether it’s starting a family...
Missy & Yan
Counsyl Foresight Carrier Screen
patients, with their daughter Sonya
Identify couples at risk to pass down serious, prevalent, clinically-actionable inherited conditions.Learn more >
Counsyl Prelude Prenatal Screen
patient, carrying her first child
Get reliable results, the first time with our non-invasive prenatal screen (NIPS).Learn more >
...or evaluating risk for cancer.
Counsyl Reliant Cancer Screen
patient, pictured with her grandmother
Help patients get ahead of cancer with our hereditary cancer screenLearn more >
The clinical impact of our genetic screens help elevate the standard of care.
86% of affected
pregnancies no longer missed
86% of affected pregnancies detected by expanded carrier screening (ECS) are missed when screening for cystic fibrosis and spinal muscular atrophy alone.1Learn how ECS detects more at-risk couples for serious conditions >
76% of couples
76% of couples found by ECS to be at risk for severe or profound conditions pursued alternative reproductive actions such as prenatal diagnosis or IVF with preimplantation genetic diagnosis.2Learn more about the clinical utility of ECS >
The false positive rate of non-invasive prenatal screening (NIPS) is 100x lower than serum screening in patients <35 years old.3Learn why NIPS leads to fewer unnecessary invasive procedures >
50% of hereditary cancers are non BRCA1/2
At least 50% of hereditary cancers are caused by genes other than BRCA1 and BRCA2.4Learn how to identify more patients at high risk for hereditary cancer >
Counsyl Complete™ provides support for providers and patients throughout the screening process.
We make it easy to inform and educate your patients about genetic screening.
We strive to make screening accessible for all patients who need it.
We automate the management of results and follow up with patients.
Our board-certified genetic counselors are available on-demand for all patients to ensure results are understood.
Your patients depend on you for
your advice and answers.
So you need someone you can lean on. Someone who is committed to your patients.
We help you offer meaningful genetic screening services and support your practice
along the way.
Together, with Counsyl
for you and your patients
- Hogan et al. Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification. Clinical Chemistry 2018; doi:10.1373/clinchem.2018.286823
- Ghiossi, C.E., Goldberg, J.D., Haque, I.S. et al. J Genet Counsel (2017). https://doi.org/10.1007/s10897-017-0160-1.
- Norton, M. et al Cell free DNA analysis for noninvasive examination of trisomy. The New England Journal of Medicine April 2015; 372: 1589-1597.
- BRCA1/BRCA2 Frequency: Gabai-Kapara E, Lahad A, Kaufman B, et al. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci U S A. 2014.